Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.4/5
Laurus Labs

Laurus Labs (LAURUS IN)

61
Analysis
Health CareIndia
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
bearishSagility India
26 May 2025 14:46

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...

Logo
720 Views
Share
24 Apr 2025 06:00

Dorf-Ketal Chemicals India Pre-IPO - The Negatives - Elevated Borrowings and Tariff Uncertainty

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO.  In this note, we talk about the not-so-positive aspects of...

Logo
331 Views
Share
23 Apr 2025 02:40

Dorf-Ketal Chemicals India Pre-IPO -The Positives - Strategic Blend of Organic & Inorganic Expansion

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO.  In this note, we talk about the positive aspects of the deal.

Logo
331 Views
Share
03 Apr 2025 09:51

Decoding Trump’s Reciprocal Tariffs: Limited Shock for India, Sector Rotation Ahead

​Trump's reciprocal tariff plan on Indian goods spares pharma and IT, impacting autos, textiles, chemicals, and solar exports. Investors may shift...

Logo
287 Views
Share
02 Apr 2025 23:12

AMFI Stock Reclassification Preview (Jun 2025): Plenty of Change With More Likely

We currently forecast 40 migrations for the AMFI July reclassification. There are 2 new listings that could be added to MidCap. The forecast upward...

Logo
526 Views
Share
x